Pacific Biosciences of California Inc. (NASDAQ: PACB) started the day on February 18, 2021, with a price decrease of -3.24% at $42.74. During the day, the stock rose to $43.96 and sunk to $41.5601 before settling in for the price of $44.17 at the close. Taking a more long-term approach, PACB posted a 52-week range of $2.20-$53.69.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 8.40%. Meanwhile, its Annual Earning per share during the time was 10.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 27.30%. This publicly-traded company’s shares outstanding now amounts to $193.10 million, simultaneously with a float of $184.08 million. The organization now has a market capitalization sitting at $8.08 billion. At the time of writing, stock’s 50-day Moving Average stood at $32.07, while the 200-day Moving Average is $13.91.
While finding the extent of efficiency of the company that is accounted for 404 employees. It has generated 224,978 per worker during the last fiscal year. Meanwhile, its income per employee was -208,252. The stock had 7.62 Receivables turnover and 0.57 Total Asset turnover. For the Profitability, stocks gross margin was +38.04, operating margin was -110.62 and Pretax Margin of -92.57.
Pacific Biosciences of California Inc. (PACB) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Diagnostics & Research Industry. Pacific Biosciences of California Inc.’s current insider ownership accounts for 1.30%, in contrast to 94.62% institutional ownership. According to the most recent insider trade that took place on Feb 16, this organization’s Director sold 220,771 shares at the rate of 47.99, making the entire transaction reach 10,595,810 in total value, affecting insider ownership by 21,875. Preceding that transaction, on Feb 12, Company’s Director sold 160,000 for 49.62, making the whole transaction’s value amount to 7,939,764. This particular insider is now the holder of 0 in total.
Pacific Biosciences of California Inc. (PACB) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2020, the organization reported $0.37 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at $0.32) by $0.05. This company achieved a net margin of -92.57 while generating a return on equity of -99.58. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
Pacific Biosciences of California Inc.’s EPS increase for this current 12-month fiscal period is 27.30% and is forecasted to reach -0.76 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -1.00% through the next 5 years, which can be compared against the 10.10% growth it accomplished over the previous five years trading on the market.
Pacific Biosciences of California Inc. (NASDAQ: PACB) Trading Performance Indicators
Let’s observe the current performance indicators for Pacific Biosciences of California Inc. (PACB). It’s Quick Ratio in the last reported quarter now stands at 1.70. The Stock has managed to achieve an average true range (ATR) of 4.21. Alongside those numbers, its PE Ratio stands at $508.81, and its Beta score is 1.33. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 102.44. Similarly, its price to free cash flow for trailing twelve months is now 549.81.
In the same vein, PACB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.08, a figure that is expected to reach -0.40 in the next quarter, and analysts are predicting that it will be -0.76 at the market close of one year from today.
Technical Analysis of Pacific Biosciences of California Inc. (PACB)
If we take a close look at the recent performances of Pacific Biosciences of California Inc. (NASDAQ: PACB), its last 5-days Average volume was 5.81 million that shows progress from its year to date volume of 5.29 million. During the previous 9 days, stock’s Stochastic %D was recorded 51.82% While, its Average True Range was 4.32.
Raw Stochastic average of Pacific Biosciences of California Inc. (PACB) in the period of the previous 100 days is set at 75.65%, which indicates a major rise in contrast to 49.52% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 98.35% that was higher than 91.40% volatility it exhibited in the past 100-days period.